Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Maya Khurana

Principal, Health and Life Sciences, Oliver Wyman

Cell and gene therapies hold tremendous promise for patients and the industry, but new business models are needed to get innovations to patients.

Principal, Health and Life Sciences, Oliver Wyman